Back to HomeBeta

ICD-10 Coding for Myeloproliferative Neoplasm(D47.1, D45)

Complete ICD-10-CM coding and documentation guide for Myeloproliferative Neoplasm. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

MPNChronic Myeloproliferative Disorder

Related ICD-10 Code Ranges

Complete code families applicable to Myeloproliferative Neoplasm

D45-D47Primary Range

Other myeloproliferative diseases

This range includes specific codes for different types of myeloproliferative neoplasms, such as polycythemia vera and essential thrombocythemia.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D47.1Chronic myeloproliferative disease, unspecifiedUse when the specific type of myeloproliferative neoplasm is not yet determined.
  • Negative JAK2/CALR/MPL mutation tests
  • Bone marrow morphology description
D45Polycythemia veraUse when polycythemia vera is confirmed by WHO criteria.
  • Hemoglobin >16.0 g/dL (female) or >16.5 g/dL (male)
  • JAK2 V617F mutation
  • Bone marrow biopsy showing trilineage hyperplasia

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for myeloproliferative neoplasm

Essential facts and insights about Myeloproliferative Neoplasm

The ICD-10 code for unspecified myeloproliferative neoplasm is D47.1.

Primary ICD-10-CM Codes for myeloproliferative neoplasm

Chronic myeloproliferative disease, unspecified
Billable Code

Decision Criteria

clinical Criteria

  • Lack of specific subtype identification

Applicable To

  • Myeloproliferative neoplasm, NOS

Excludes

  • Polycythemia vera (D45)
  • Essential thrombocythemia (D47.3)

Clinical Validation Requirements

  • Negative JAK2/CALR/MPL mutation tests
  • Bone marrow morphology description

Code-Specific Risks

  • Risk of under-coding if specific subtype is known but not documented.

Coding Notes

  • Ensure to update the code once the specific subtype of MPN is confirmed.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Abnormal coagulation profile

R79.1
Use when there are abnormal coagulation test results associated with MPN.

Splenomegaly

R16.1
Use when splenomegaly is present with polycythemia vera.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Polycythemia vera

D45
Confirmed by elevated hemoglobin and JAK2 mutation.

Essential thrombocythemia

D47.3
Confirmed by sustained elevated platelet count and megakaryocyte proliferation.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Myeloproliferative Neoplasm to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D47.1.

Impact

Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with ICD-10 coding standards., Financial: Potential loss of reimbursement for specific treatments.

Mitigation Strategy

Regularly review patient records for updated diagnostic information., Implement alerts in EHR for code updates.

Impact

Reimbursement: May affect reimbursement rates due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of patient records.

Mitigation Strategy

Update the code to reflect the specific subtype once confirmed.

Impact

Risk of audits due to incorrect or unspecified coding of MPN subtypes.

Mitigation Strategy

Ensure thorough documentation and regular code reviews.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Myeloproliferative Neoplasm, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Myeloproliferative Neoplasm

Use these documentation templates to ensure complete and accurate documentation for Myeloproliferative Neoplasm. These templates include all required elements for proper coding and billing.

Diagnosis of Polycythemia Vera

Specialty: Hematology

Required Elements

  • JAK2 mutation status
  • Hemoglobin levels
  • Bone marrow biopsy results

Example Documentation

Assessment: Polycythemia Vera confirmed by JAK2 V617F mutation and elevated hemoglobin.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has high red blood cell count.
Good Documentation Example
Patient diagnosed with Polycythemia Vera, confirmed by JAK2 V617F mutation and hemoglobin of 17.5 g/dL.
Explanation
The good example provides specific diagnostic criteria and mutation status, which are necessary for accurate coding.

Need help with ICD-10 coding for Myeloproliferative Neoplasm? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more